Is Neurocrine Biosciences, Inc. (NBIX) a Buy, Sell, or Hold?
NASDAQ : NBIX
Neurocrine Biosciences, Inc. — Analyst Ratings
$166.8 USD
-$18.7 (-10.08%)
- Volume
- 4.58M
- Average Volume
- 1.29M
- Market Capitalization
- $16.77B
- P/E Ratio
- 23.66
- Dividend Yield
- 0.00%
- Price Target
- $200.00
- Year High
- $186.12
- Year Low
- $122.14
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.87
Analyst Consensus Summary
Consensus Rating
Buy
37 Analysts
Rating Score
4/5
Recommendation Strength
Upside/Downside
-16.6%
vs Current Price
Price Target
$200.00
Average TargetPrice Target Range
Lowest Target
$160.00
4.3% UPSIDE
Average Target
$200.00
Median Estimate
Highest Target
$230.00
-27.5% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 37
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 32 | 5 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Deutsche Bank | David Hoang | $190 | $165.9319 | 2026-07-31 08:54 AM | 14.5% |
| Piper Sandler | GAAP EPS | $210 | $185.5 | 2026-07-31 07:34 AM | 13.2% |
| Robert W. Baird | Brian Skorney | $225 | $185.5 | 2026-07-31 07:21 AM | 21.3% |